JP2023516977A5 - - Google Patents

Info

Publication number
JP2023516977A5
JP2023516977A5 JP2022552314A JP2022552314A JP2023516977A5 JP 2023516977 A5 JP2023516977 A5 JP 2023516977A5 JP 2022552314 A JP2022552314 A JP 2022552314A JP 2022552314 A JP2022552314 A JP 2022552314A JP 2023516977 A5 JP2023516977 A5 JP 2023516977A5
Authority
JP
Japan
Prior art keywords
compound according
unsubstituted
substituted
independently
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022552314A
Other languages
English (en)
Japanese (ja)
Other versions
JP7716112B2 (ja
JP2023516977A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020450 external-priority patent/WO2021178396A1/en
Publication of JP2023516977A publication Critical patent/JP2023516977A/ja
Publication of JP2023516977A5 publication Critical patent/JP2023516977A5/ja
Application granted granted Critical
Publication of JP7716112B2 publication Critical patent/JP7716112B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022552314A 2020-03-02 2021-03-02 免疫細胞へのin vivoでのmRNA送達のためのイミダゾール系合成リピドイド Active JP7716112B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062983997P 2020-03-02 2020-03-02
US62/983,997 2020-03-02
PCT/US2021/020450 WO2021178396A1 (en) 2020-03-02 2021-03-02 Imidazole-based synthetic lipidoids for in vivo mrna delivery into immune cells

Publications (3)

Publication Number Publication Date
JP2023516977A JP2023516977A (ja) 2023-04-21
JP2023516977A5 true JP2023516977A5 (enExample) 2024-03-13
JP7716112B2 JP7716112B2 (ja) 2025-07-31

Family

ID=77613658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022552314A Active JP7716112B2 (ja) 2020-03-02 2021-03-02 免疫細胞へのin vivoでのmRNA送達のためのイミダゾール系合成リピドイド

Country Status (6)

Country Link
US (1) US20230097743A1 (enExample)
EP (1) EP4114467A4 (enExample)
JP (1) JP7716112B2 (enExample)
CN (1) CN115461083A (enExample)
CA (1) CA3170055A1 (enExample)
WO (1) WO2021178396A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230005367A (ko) * 2020-05-04 2023-01-09 트러스티즈 오브 터프츠 칼리지 뇌 전달을 위한 합성 지질-유사 물질
US20250268828A1 (en) * 2021-09-30 2025-08-28 Orna Therapeutics, Inc. Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides
WO2023081526A1 (en) 2021-11-08 2023-05-11 Orna Therapeutics, Inc. Lipid nanoparticle compositions for delivering circular polynucleotides
CN114805212B (zh) * 2022-02-22 2024-06-18 中国科学院基础医学与肿瘤研究所(筹) 用于递送治疗或预防剂的脂质和脂质组合物
CN119486721A (zh) 2022-07-08 2025-02-18 宝利普拉斯生物转染公司 包含基于咪唑鎓的阳离子脂质的脂质纳米颗粒
WO2024205657A2 (en) * 2023-03-29 2024-10-03 Orna Therapeutics, Inc. Lipids and lipid nanoparticle compositions for delivering polynucleotides
WO2025124548A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 一种咪唑类脂质及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097475A (en) * 1974-04-03 1978-06-27 E. I. Du Pont De Nemours And Company Disperse mono- and bisazo dyes derived from 2-amino-4,5-dicyanoimidazole
US20040132788A1 (en) * 1999-10-11 2004-07-08 Chabrier De Lassauniere Pierre-Etienne Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
WO2006138380A2 (en) * 2005-06-15 2006-12-28 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
KR101363278B1 (ko) * 2005-06-27 2014-02-21 엑셀리시스 페이턴트 컴퍼니 엘엘씨 이미다졸계 lxr 변조제
WO2010062322A2 (en) * 2008-10-27 2010-06-03 Massachusetts Institute Of Technology Modulation of the immune response
US9512073B2 (en) * 2011-10-27 2016-12-06 Massachusetts Institute Of Technology Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
IL276322B2 (en) * 2018-02-01 2024-12-01 Tufts College Lipid-like nanocomplexes and uses thereof

Similar Documents

Publication Publication Date Title
JP2021512865A5 (enExample)
CN114728016B (zh) 脂质组合物
JP2023524747A5 (enExample)
Gallego-Yerga et al. Cyclodextrin-and calixarene-based polycationic amphiphiles as gene delivery systems: a structure–activity relationship study
CN115784921B (zh) 肝外靶向高效低毒的阳离子脂质化合物及其组合物
US20220323369A1 (en) Synthetic lipid-like materials for brain delivery
EP3981435A1 (en) Lipid composition
PL182237B1 (pl) Sposób przeprowadzania transfekcji komórek i osiagniecia biodostepnosci materialu genetycznego in vitro i ex vivo PL PL
WO2021178396A1 (en) Imidazole-based synthetic lipidoids for in vivo mrna delivery into immune cells
CN102863557A (zh) 乳糖酸修饰的脂肪酸-三甲基壳聚糖聚合物制备方法及应用
CN119455013A (zh) 基于介孔聚多巴胺纳米粒子的靶向药物递送载体及应用
WO2014084378A1 (ja) 環状rgd配列含有ペプチドを含む抗癌剤
CN111643678B (zh) 基于含巯基的两性离子多肽修饰的阿霉素衍生物、纳米胶束及其制备方法
JP2023529882A5 (enExample)
CN107805303B (zh) 具有氧化还原敏感性的靶向聚合物及其载药胶束的制备方法和用途
CN107951839A (zh) 一种具有电荷可翻转的聚离子型胶束遮蔽体系及其制备方法
CN102558546B (zh) 聚乙二醇甘草次酸酯、复合载药胶束及其制备方法和用途
CN115093434B (zh) 一种藤黄酸纳米制剂及其制备方法
CN116018142A (zh) 用于细胞内mRNA递送的PH响应性类脂质纳米颗粒
WO2021221167A1 (ja) ガン治療薬及びガン治療方法
KR102917928B1 (ko) 신규한 이온화 지질 및 이를 이용한 지질 나노입자 조성물
CN111686076B (zh) 载阿霉素聚合物胶束及其制备方法与应用
CN115531310B (zh) 一种甲基莲心碱/阿霉素纳米混合胶束及其制备方法
CN120943786A (zh) 脂质化合物、其纳米颗粒及应用
HK40081633B (en) Novel cationic lipid compound with long-term effectiveness and low toxicity and its composition